These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3970857

  • 1. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G, Tran TH, Barbui T, Duckert F.
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [Abstract] [Full Text] [Related]

  • 2. Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III 'Vicenza').
    Barbui T, Finazzi G, Rodeghiero F, Dini E.
    Br J Haematol; 1983 Aug; 54(4):561-5. PubMed ID: 6871107
    [Abstract] [Full Text] [Related]

  • 3. Abnormal reactivity with thrombin of a new variant of dysfunctional antithrombin (AT 'Vicenza').
    Finazzi G, Barbui T, Tran TH, Duckert F.
    Ric Clin Lab; 1984 Aug; 14(3):515-9. PubMed ID: 6522961
    [No Abstract] [Full Text] [Related]

  • 4. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M, Petersen LC, Thorsen S.
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [Abstract] [Full Text] [Related]

  • 5. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA, Flynn A, Ireland H, Erdjument H, Samson D, Howarth D, Thompson E.
    Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate.
    Caso R, Lane DA, Thompson EA, Olds RJ, Thein SL, Panico M, Blench I, Morris HR, Freyssinet JM, Aiach M.
    Br J Haematol; 1991 Jan; 77(1):87-92. PubMed ID: 1998601
    [Abstract] [Full Text] [Related]

  • 9. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [Abstract] [Full Text] [Related]

  • 10. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
    Ireland H, Lane DA, Thompson E, Walker ID, Blench I, Morris HR, Freyssinet JM, Grunebaum L, Olds R, Thein SL.
    Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
    [Abstract] [Full Text] [Related]

  • 11. Studies of the heterogeneity of antithrombin III concentrates.
    Barrowcliffe TW, Eggleton CA, Mahmoud M.
    Br J Haematol; 1983 Sep; 55(1):37-46. PubMed ID: 6882687
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Purification and properties of guinea pig antithrombin III.
    Heck L, Rosenberg R, Remold H.
    Prep Biochem; 1979 Sep; 9(4):359-77. PubMed ID: 504072
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT, Müller-Berghaus G.
    Eur J Biochem; 1986 May 02; 156(3):645-50. PubMed ID: 3699029
    [Abstract] [Full Text] [Related]

  • 18. A highly purified antithrombin III concentrate prepared from human plasma fraction IV-1 by affinity chromatography.
    Lebing WR, Hammond DJ, Wydick JE, Baumbach GA.
    Vox Sang; 1994 May 02; 67(2):117-24. PubMed ID: 7801599
    [Abstract] [Full Text] [Related]

  • 19. Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum.
    Preissner KT, Zwicker L, Müller-Berghaus G.
    Biochem J; 1987 Apr 01; 243(1):105-11. PubMed ID: 3606566
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D, Schetz J, de Cock F, Holmer E, Verstraete M.
    Eur J Clin Invest; 1977 Feb 01; 7(1):27-35. PubMed ID: 65284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.